Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T
SpotifyDescription
AML isn’t just a disease of older adults. In this episode with Dr Emily Hsieh, we explore how treatment differs for pediatric AML patients and the promising research - including CAR-T therapy - that could change the game.
Thank you for listening! Reach out to Mary at mary@healthtree.org if you are interested in joining our Pediatric Advisory Board or to share your thoughts about today's episode.
To keep learning about today's topic, check out these additional resources mentioned in today's episode!
If you want to talk to other listeners about this episode, join HealthTree Connect below and start the conversation!
Overview
This podcast episode discusses the complexities of treating pediatric acute myeloid leukemia (AML) and the potential of CAR-T therapy as a treatment option. Dr. Emily Shea shares insights on the unique challenges faced by pediatric patients, the current research landscape, and the importance of clinical trials. The conversation emphasizes the need for targeted therapies and the significance of patient advocacy in advancing treatment options for this vulnerable population.
Mary Arnett
Dr. Emily Hsieh
Transcript